Etienne Deffarges is a serial entrepreneur, active angel investor, and author of Untangling the USA. As a senior partner with Booz Allen Hamilton and global managing partner with Accenture, he advised businesses and governments all over the world and orchestrated billion-dollar deals. In 2004, Etienne helped start healthcare IT Accretive Health (now R1 RCM), growing it from the proverbial "blank sheet of paper" to a 2010 IPO valuing the company at $1.2 billion. An active angel investor and start-up advisor, he serves on boards of aerospace, automotive, construction, energy, food, and healthcare.
Artificial Intelligence will help develop new cures, but to solve access and cost issues in U.S. health care, we will need new policies at the federal and state government level. Billions of dollars are being invested annually in artificial intelligence (AI), by large health care insurers, pharmaceutical companies, and venture capitalists.
The U.S. Government as a leading venture capitalist, wow, is this a joke? This sounds like industrial policy, public intervention, and “picking winners.” It is something that European and East Asian governments do, but not us, right? Think again. The U.S. government has actually played a major role in developing many innovations used by our technology giants to reach worldwide dominance.